Myasthenia gravis is an autoimmune disorder of the nervous system characterized by auto-antibodies attacking the nicotinic acetylcholine receptor at the neuromuscular junction.
Treatment of myasthenia gravis frequently involves the use of cholinesterase inhibitors.